HOSPITAL UNIVERSITARIO QUIRÓNSALUD MADRID
Departamento
University of California Los Angeles
Los Ángeles, Estados UnidosPublicaciones en colaboración con investigadores/as de University of California Los Angeles (2)
2023
-
Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?
Clinical Genitourinary Cancer, Vol. 21, Núm. 3, pp. e93-e103
-
PSMA PET/CT imaging for biochemical recurrence of prostate cancer after radiotherapy: is it necessary to review the Phoenix criteria?
Clinical and Translational Imaging, Vol. 11, Núm. 3, pp. 241-254